Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A
NYSE:DNA 4:00:00 PM EDT
| Market Cap (Intraday) | 2.82B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.44 |
| 50-Day MA | $1.56 |
| 200-Day MA | $1.64 |
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, NYSE:DNA
27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210
United States of America
Phone: +1.877.422.5362
Number of Employees: 1292
Description
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.